Avalon Global Asset Management LLC Jazz Pharmaceuticals PLC Transaction History

Avalon Global Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $2.9 Million - $3.33 Million	-23,060 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $609,050 - $714,750	-5,000 Reduced 17.82%	23,060 $3.3 Million
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $107,824 - $155,068	930 Added 3.43%	28,060 $3.48 Million
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $677,950 - $785,800	5,000 Added 22.59%	27,130 $4.1 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $3.16 Million - $3.44 Million	22,130	22,130 $3.24 Million

510

57.6M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.74B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Avalon Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avalon Global Asset Management LLC with notifications on news.